Shionogi and MPP sign licence agreement for COVID-19 oral antiviral treatment
Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.
Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.
Mandaviya felicitated voluntary blood donors and states/UTs that have done exemplary work
‘PathoDetect HPV Detection Test’ detects and discriminates the presence of high-risk HPV strains including 16 and 18 which cause most of the cervical cancers.
The committee unanimously decided to confer the Lifetime Achievement Award to Kiran Mazumdar-Shaw for her monumental contributions as a global leader in biotechnology innovation and entrepreneurship
India's healthcare system has shown great efficiency not only in providing diagnostic and management facilities but also in minimizing mortality and maximizing recovery
AB PMJAY has been successful in providing quality health services to the beneficiaries who come from weak financial backgrounds
Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune
Despite the technological advancements, there remains no alternative to blood and one unit of blood can save as many as three lives
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India
This will give a boost to cost-effective, quality medicines and contribute towards reduction in out of pocket expenditure on healthcare for the citizens
Subscribe To Our Newsletter & Stay Updated